Zoledronate alters natural progression of tissue‐engineered vascular grafts

Author:

Chang Yu‐Chun12,Li Junlang1,Mirhaidari Gabriel12,Zbinden Jacob13,Barker Jenny14,Blum Kevin13,Reinhardt James1ORCID,Best Cameron12ORCID,Kelly John1,Shoji Toshihiro1,Yi Tai1,Breuer Christopher1

Affiliation:

1. Center for Regenerative Medicine at the Abigail Wexner Research Institute Nationwide Children's Hospital Columbus Ohio USA

2. Biomedical Sciences Graduate Program The Ohio State University College of Medicine Columbus Ohio USA

3. Department of Biomedical Engineering The Ohio State University College of Engineering Columbus Ohio USA

4. Department of Plastic and Reconstructive Surgery The Ohio State University Medical Center Columbus Ohio USA

Funder

National Institutes of Health

American Heart Association

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Reference42 articles.

1. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006;Gilboa Suzanne M;Circulation,1999

2. Complications and Risk Factors for Mortality During Congenital Heart Surgery Admissions

3. Trends in Congenital Heart Disease

4. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure

5. Tissue‐engineered blood vessels in pediatric cardiac surgery;Shinoka T;Yale J Biol Med,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3